Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 589

Showing 1-25 of 589 citing articles:

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1143
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee, Jens Rauch, Walter Kölch
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1102-1102
Open Access | Times Cited: 637
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
Yuening Xiang, Zimu Guo, Pengfei Zhu, et al.
Cancer Medicine (2019) Vol. 8, Iss. 5, pp. 1958-1975
Open Access | Times Cited: 618
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi, Frédéric J. de Sauvage
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 1, pp. 39-56
Closed Access | Times Cited: 602
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho, Alex H. Y. Chan, A. Ganesan
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12460-12484
Open Access | Times Cited: 571
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Helai P. Mohammad, Olena Barbash, Caretha L. Creasy
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 403-418
Closed Access | Times Cited: 381
A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park, Jeong‐Sun Kim
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 2, pp. 204-212
Open Access | Times Cited: 370
Overview of Histone Modification
Yanjun Zhang, Zhongxing Sun, Junqi Jia, et al.
Advances in experimental medicine and biology (2020), pp. 1-16
Closed Access | Times Cited: 336
The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics
Edward Pajarillo, Asha Rizor, Jayden Lee, et al.
Neuropharmacology (2019) Vol. 161, pp. 107559-107559
Open Access | Times Cited: 335
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
Annelisa M. Cornel, Iris Mimpen, Stefan Nierkens
Cancers (2020) Vol. 12, Iss. 7, pp. 1760-1760
Open Access | Times Cited: 326
Targeting Cancer Cell Dormancy
Ariadna Recasens, Lenka Munoz
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 2, pp. 128-141
Closed Access | Times Cited: 291
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Genes (2020) Vol. 11, Iss. 5, pp. 556-556
Open Access | Times Cited: 271
Targeting FAK in anticancer combination therapies
John C. Dawson, Alan Serrels, Dwayne G. Stupack, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 313-324
Open Access | Times Cited: 263
Cancer Epigenetics, Tumor Immunity, and Immunotherapy
Jian Cao, Qin Yan
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 580-592
Open Access | Times Cited: 252
Trends and Challenges in Tumor Anti-Angiogenic Therapies
József Jászai, Mirko H. H. Schmidt
Cells (2019) Vol. 8, Iss. 9, pp. 1102-1102
Open Access | Times Cited: 186
Role of HDACs in normal and malignant hematopoiesis
Pan Wang, Zi Wang, Jing Liu
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 180
Epigenetics in cancer therapy and nanomedicine
Annalisa Roberti, Adolfo Fernández, Ramón Torrecillas, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 179
HDAC Inhibitors in Acute Myeloid Leukemia
Edurne San José‐Eneriz, Naroa Gimenez-Camino, Xabier Agirre, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1794-1794
Open Access | Times Cited: 176
Chromatin regulatory mechanisms and therapeutic opportunities in cancer
Alfredo M. Valencia, Cigall Kadoch
Nature Cell Biology (2018) Vol. 21, Iss. 2, pp. 152-161
Open Access | Times Cited: 175
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer
William M. Grady, Ming Yu, Sanford D. Markowitz
Gastroenterology (2020) Vol. 160, Iss. 3, pp. 690-709
Open Access | Times Cited: 172
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 170
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter, Katie Hege, Jay Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 165
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
Brandie C. Taylor, Justin M. Balko
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 154
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Lourdes Hontecillas‐Prieto, Rocío Flores-Campos, Andrew Silver, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 142
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 140
Page 1 - Next Page

Scroll to top